Projects per year
Fingerprint
Dive into the research topics where Kyle B Williams is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects and Grants
- 1 Finished
-
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology
Larsson, A. T., Bhatia, H., Calizo, A., Pollard, K., Zhang, X., Conniff, E., Tibbitts, J. F., Rono, E., Cummins, K., Osum, S. H., Williams, K. B., Crampton, A. L., Jubenville, T., Schefer, D., Yang, K., Lyu, Y., Pino, J. C., Bade, J., Gross, J. M., Lisok, A., & 8 others , Nov 1 2023, In: Neuro-Oncology. 25, 11, p. 2044-2057 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas
Williams, K. B., Marley, A. R., Tibbitts, J., Moertel, C. L., Johnson, K. J., Linden, M. A., Largaespada, D. A. & Marcotte, E. L., Dec 2023, In: BMC Research Notes. 16, 1, 275.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity (Oncotarget (2014) 5 (1502–1514) DOI: 10.18632/oncotarget.1609)
Watson, A. L., Keller, B. J., Williams, K. A., Damle, N. N., Finnerty, S. J., Anderson, L. K., Greeley, A. D., Keng, V. W., Rahrmann, E. P., Halfond, A. L., Powell, N. M., Collins, M. H., Rizvi, T., Moertel, C. L., Ratner, N. & Largaespada, D. A., Sep 29 2020, In: Oncotarget. 11, 39, p. 3618-3620 3 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Implication of znf217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K–AKT signaling for the treatment of metastatic osteosarcoma
Smeester, B. A., Draper, G. M., Slipek, N. J., Larsson, A. T., Stratton, N., Pomeroy, E. J., Becklin, K. L., Yamamoto, K., Williams, K. B., Laoharawee, K., Peterson, J. J., Abrahante, J. E., Rathe, S. K., Mills, L. J., Crosby, M. R., Hudson, W. A., Rahrmann, E. P., Largaespada, D. A. & Moriarity, B. S., Dec 1 2020, In: Molecular Cancer Therapeutics. 19, 12, p. 2528-2541 14 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Implication of znf217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K–AKT signaling for the treatment of metastatic osteosarcoma
Smeester, B. A., Draper, G. M., Slipek, N. J., Larsson, A. T., Stratton, N., Pomeroy, E. J., Becklin, K. L., Yamamoto, K., Williams, K. B., Laoharawee, K., Peterson, J. J., Abrahante, J. E., Rathe, S. K., Mills, L. J., Crosby, M. R., Hudson, W. A., Rahrmann, E. P., Largaespada, D. A. & Moriarity, B. S., Dec 1 2020, In: Molecular Cancer Therapeutics. 19, 12, p. 2528-2541 14 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations